TIMOTHY IRIZARRY: Open Payments
NPI 1871826958 · DUMAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 4 payments from 4 companies in 2025. Trend: 2023 $61 · 2024 $32 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $118 |
| ABBVIE INC. | 1 | $113 |
| Novo Nordisk Inc | 1 | $98 |
| Otsuka America Pharmaceutical, Inc. | 1 | $95 |
Products named: INGREZZA, VRAYLAR, Ozempic, REXULTI.
Industry payments across AR — which companies pay providers there.
